Abstract

Mesenchymal stem/stromal cells isolated from chorionic villi of human term placentae (CV-MSCs) possess unique biological characters. They exhibit self-renewal, directional migration, differentiation, and immunomodulatory effects on other cell lineages, by virtue of which they can be utilized as therapeutic carriers, for drug targeting, and therapy. Tumors display characteristic features of a damaged tissue microenvironment, which is saturated with conditions such as hypoxia, sustained inflammation, and increased oxidative stress. CV-MSCs function normally in a high oxidative stress environment induced by hydrogen peroxide (H2O2) and glucose and also protect endothelial cells from their damaging effects. For their therapeutic applications in a disease like cancer, it is necessary to ascertain the effects of tumor microenvironment on their functional outcome. In this study, we investigated the functional activities, of CV-MSCs in response to conditioned media (CM) obtained from the culture of breast cancer cell line MDA-231 (CM-MDA231). CV-MSCs were exposed to CM-MDA231 for different spatio-temporal conditions, and their biological functions as well as modulation in gene expression were evaluated. Effect of CM-MDA231 on factors responsible for changes in functional outcome were also investigated at the protein levels. CV-MSCs exhibited significant reduction in proliferation but increased adhesion and migration after CM-MDA231 treatment. Interestingly, there was no change in their invasion potential. CM-MDA231 treatment modulated expression of various genes involved in important cellular events including, integration, survival, message delivery and favorable outcome after transplantation. Analysis of pathways related to cell cycle regulation revealed significant changes in the expression of p53, and increased phosphorylation of Retinoblastoma (Rb) and Checkpoint Kinase 2 in CV-MSCs treated with CM-MDA231. To summarize, these data reveal that CV-MSCs retain the ability to survive, adhere, and migrate after sustained treatment with CM-MDA231, a medium that mimics the cancer microenvironment. These properties of CV-MSCs to withstand the inflammatory tumor like microenvironment prove that they may make useful candidate in a stem cell based therapy against cancer. However, further pre-clinical studies are needed to validate their therapeutic usage.

Highlights

  • Cancer is the second leading cause of death globally after cardiovascular disease

  • Further study the effects of Conditioned medium (CM)-MDA231 preconditioning on cellular functions of CV-MSCs, and because preconditioning has resulted in significant decrease in their proliferative potential, we examined modulation of the proteins involved in cell cycle arrest, including the p53, Retinoblastoma (Rb) and Checkpoint kinase-2 (Chk2)

  • CV-MSCs isolated from the chorionic villi of human placentae express and secrete several important factors which have ability to modify the functional activities of their target cells (Abumaree et al, 2013b)

Read more

Summary

Introduction

An estimated count of 9.6 million people died because of cancer in 2018, as per the latest WHO report It accounts for about 1 in 6 deaths globally (Cancer, 2020; A WHO Report). Many treatment options including surgery, radiotherapy, chemotherapy, cancer vaccines, immunotherapy and CAR-T-cell therapy are available and used successfully against many cancers, yet the overall outcome is abysmal because of multiple reasons. It may because of the non-specific targets, off target effects, therapy resistance and tumor recurrence, etc. Stem cells are preferred for their therapeutic efficacy because of their enhanced targeting of tumors and minimizing the off-target effects (Gomes et al, 2017)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.